CRISPR/Cas9 genome editing to treat sickle cell disease

CRISPR/Cas9 genome editing to treat sickle cell disease

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.

Opis bibliograficzny
1. autor: Ullah, Mohammad
Kolejni autorzy: Islam, Farzana
Format: Praca dyplomowa
Język:English
Wydane: Brac University 2023
Hasła przedmiotowe:
SCD
CRISPR/Cas9
Hematopoietic stem/progenitor cells
Fetal hemoglobin
Gene editing tools
Genetic engineering > Research
Gene therapy > Research
Biotechnology
Dostęp online:http://hdl.handle.net/10361/19355
Opis
Streszczenie:This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.

Podobne zapisy